Trends in prevalence, awareness, treatment and control of hypertension in urban communities in Chile

Journal of Hypertension

Volumn 25, Issue 9, 2007, Pages 1807-1811

  Fasce, Eduardo ^a   Campos, Ivone ^a   Ibáñez, Pilar ^a   Flores, Maritza ^a   Zárate, Hernán ^a   Román, Oscar ^a   Fasce, Fabrizio ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

Blood pressure; Detection and control of hypertension; Population; Prevalence

Indexed keywords

AMLODIPINE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; HYDROCHLOROTHIAZIDE; LONG ACTING DRUG; NIFEDIPINE; THIAZIDE DIURETIC AGENT;

ADOLESCENT; ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; AWARENESS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CHILE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GROUPS BY AGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SAMPLE (STATISTICS); SEX RATIO; SOCIOECONOMICS; STRATIFICATION; SYSTOLIC BLOOD PRESSURE; URBAN POPULATION;

EID: 34548433493     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328244e481     Document Type: Article

References (40)

1. Murray C, Lopez A. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349:1436-1442.
2. Stamler J. Blood pressure and high blood pressure: aspects of risk. Hypertension 1991; 18 (Suppl I):95-107.
3. Flack JM, Neaton J, Grimm R, Shih J, Cutler J, Ensrud K, MacMahon S, for the Multiple Risk Factor Intervention Trial Research Group. Blood pressure and mortality among men with prior myocardial infarction. Circulation 1995; 92:2437-2445.
4. Levy D. The role of systolic blood pressure in determining risk for cardiovascular disease. J Hypertens 1999; 17 (Suppl 1):15-18.
5. Benetos A. Pulse pressure and cardiovascular risk. J Hypertens 1999; 17 (Suppl 5):21-24.
6. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risk of stroke and of coronary heart disease. Br Med Bull 1994; 50:272-298.
7. Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial on Older Patients with Hypertension (STOP - Hypertension). Lancet 1991; 338:1281-1285.
8. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304:405-412.
9. Hypertension Detection and Follow up Program Cooperative Group. Five year findings of the Hypertension Detection and Follow up Program. II. Mortality by race, sex and age. JAMA 1979; 242:2572-2577.
10. Wang J, Staessen J, Gong L, Liu L. Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group. Arch Intern Med 2000; 160:211-220.
11. Systolic Hypertension in the Elderly Program Cooperative Research Group. Implications of the Systolic Hypertension in the Elderly Program. Hypertension 1993; 21:335-343.
12. Staessen JA, Fagard R, Thijs L, Celis H, Arabitze G, Birkenhäger N, et al., for the Systolic Hypertension-Europe (Syst-Eur) Trial Investigators. Morbidity and mortality in the placebo-controlled European trial on isolated systolic hypertension in the elderly. Lancet 1997; 350:757-764.
13. Whelton PK, Appel LJ, Espeland MA, Applegate W, Ettinger W, Kostis J, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: A randomized controlled Trial Of Nonpharmacologic interventions in the Elderly (TONE). JAMA 1998; 279:839-846.
14. Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic intervention on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention phase I. JAMA 1992; 267:1213-1220.
15. Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure: the Trials of Hypertension Prevention phase II. Arch Intern Med 1997; 157:657-667.
16. Appel LJ, Moore TJ, Obarzanek E, Vollmer W, Svetkey L, Sacks F, et al., for the DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997; 336:1117-1124.
17. Pearson T, Blair S, Daniels S, Eckel R, Fair J, Fortman S, et al., American Heart Association Science Advisory and Coordinating Committee. AHA guideliness for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or atherosclerotic vascular disease. Circulation 2002; 106:388-391.
18. Stamler R, Stamler J, Gosch FC, Civanelli J, Fishman J, McKeever P, et al. Primary prevention of hypertension by nutritional-hygienic means: final report of a randomized, controlled trial. JAMA 1989; 262:1801-1807.
19. Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Arch Intern Med 1990; 150:153-162.
20. Fasce E, Pérez H, Boggiano G, Lecannelier E. La hipertensión arterial en una comunidad urbana de Chile. Rev Chil Cardiol 1992; 1:1-12.
21. Fasce E, Pérez H, Boggiano G, Ibáñez P, Nieto C. Hipertensión arterial en comunidades rurales de la VIII Región. Rev Med Chile 1993; 121:1058-1067.
22. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion J, Mancia G, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21:821-848.
23. Krumholz H, Peterson E, Ayanian J, Chin M, DeBusk R, Goldman L, et al. Report of the National Heart, Lung, and Blood Institute Working Group on Outcomes Research in Cardiovascular Disease. Circulation 2005; 111:3158-3166.
24. Birkett NJ. The effect of alternative criteria for hypertension on estimates of prevalence and control. J Hypertens 1997; 15:237-244.
25. Wolf-Maier K, Cooper R, Kramer H, Banegas J, Giampaoli S, Joffres M, et al. Hypertension Treatment and Control in Five European Countries, Canada and the United Sates. Hypertension 2004; 43:10-17.
26. Lawes C, Vander Hoorn S, Law M, Elliot P, MacMahon S, Rodgers A, et al. Blood pressure and the global burden of disease 2000. Part 1: Estimates of blood pressure levels. J Hypertens 2006; 24:413-422.
27. Haijar I, Kotchen T. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290:199-206.
28. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension 2002; 40:920-927.
29. Kearney P, Whelton M, Reynolds K, Muntner P, Whelton P, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217-223.
30. Thamm M. Blood pressure in Germany: current status and trends. Gesundheitswessen 1999; 61:S90-S93.
31. National Cardiovascular Disease Database. Cardiovascular risk factors report. AIHW analysis of the NHF Risk Factor Prevalence Study. Available at web site http://www.aihw.gov.au/pls/cvd/cvd_risk.show_form (accessed November 2006).
32. Joffres M, Ghadirian P, Fodor J, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment and control of hypertension in Canada. Am J Hypertens 1997; 10:1097-1102.
33. Wolz M, Cutler J, Roccella E, Rohde F, Thom T, Burt V. Statement from the National High Pressure Education Program: prevalence of hypertension. Am J Hypertens 2000; 13:103-104.
34. Primatesta P, Brookes M, Poulter N. Improved hypertension management and control: results from the health survey for England 1988. Hypertension 2001; 38:827-832.
35. Banegas J, Rodríguez-Artalejo F, de la Cruz Troca J, Guallar-Castillo P, del Rey Calero J. Blood pressure in Spain: distribution, awareness, control, and benefits of a reduction in average pressure. Hypertension 1998; 32:998-1002.
36. Giampaoli S, Palmieri L, Dima F, Pilotto L, Vescio M, Vanuzzo D. Socioeconomic aspects and cardiovascular risk factors: experience at the Cardiovascular Epidemiologic Observatory. Ital Heart J 2001; 2:294-302.
37. Persson M, Carlberg B, Mjorndal T, Asplund K, Bohlin J, Lindholm L. The 1999 WHO/ISH Hypertension Guidelines: 1999 WHO/ISH Guidelines applied to a 1999 MONICA sample from northern Sweden. J Hypertens 2002; 20:29-35.
38. Bovet P, Gervasoni JP, Ross A, Mkamba M, Mtasiwa D, Lengeler C, et al. Assessing the prevalence of hypertension in populations: are we doing it right? J Hypertens 2003; 21:509-517.
39. Arroyo P, Fernández V, Loria A. Hypertension in urban Mexico: the 1992-93 national survey of chronic diseases. J Hum Hypertens 1999; 13:671-675.
40. Sulbaran T, Silva E, Calmon G, Vegas A. Epidemiologic aspects of arterial hypertension in Maracaibo, Venezuela. J Hum Hypertens 2000; 14:S6-S9.